20:53 , Oct 4, 2017 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: September 2017

New Therapeutic Targets and Biomarkers: September 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during September 2017. Therapeutic targets are defined as any protein, gene or other...
18:17 , Sep 27, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Viral hemorrhagic fever Non-human primates studies suggest mAbs against Lassa virus glycoprotein could help prevent or treat Lassa fever. In a cynomolgus macaque lethal Lassa virus challenge model, each of five human mAbs against...
22:54 , Sep 6, 2017 |  BC Extra  |  Preclinical News

Human mAbs could treat Lassa fever

In a paper published in Nature Medicine , researchers at the University of Texas , Tulane University and Zalgen Labs LLC (Germantown, Md.) showed that Lassa virus glycoprotein-neutralizing mAbs rescued non-human primates infected with Lassa...